• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒作为传染性疾病和癌症的疫苗载体。

Viruses as vaccine vectors for infectious diseases and cancer.

机构信息

The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ, UK.

出版信息

Nat Rev Microbiol. 2010 Jan;8(1):62-73. doi: 10.1038/nrmicro2240.

DOI:10.1038/nrmicro2240
PMID:19966816
Abstract

Recent developments in the use of viruses as vaccine vectors have been facilitated by a better understanding of viral biology. Advances occur as we gain greater insight into the interrelationship of viruses and the immune system. Viral-vector vaccines remain the best means to induce cellular immunity and are now showing promise for the induction of strong humoral responses. The potential benefits for global health that are offered by this field reflect the scope and utility of viruses as vaccine vectors for human and veterinary applications, with targets ranging from certain types of cancer to a vast array of infectious diseases.

摘要

最近,随着对病毒生物学的深入了解,病毒作为疫苗载体的应用得到了进一步的发展。随着我们对病毒与免疫系统之间相互关系的认识不断加深,新的进展也不断涌现。病毒载体疫苗仍然是诱导细胞免疫的最佳手段,现在也显示出诱导强烈体液免疫反应的潜力。该领域为全球健康带来的潜在好处反映了病毒作为人类和兽医应用疫苗载体的范围和效用,其目标包括某些类型的癌症和各种传染病。

相似文献

1
Viruses as vaccine vectors for infectious diseases and cancer.病毒作为传染性疾病和癌症的疫苗载体。
Nat Rev Microbiol. 2010 Jan;8(1):62-73. doi: 10.1038/nrmicro2240.
2
Novel viral vectors in infectious diseases.传染病中的新型病毒载体
Immunology. 2018 Jan;153(1):1-9. doi: 10.1111/imm.12829. Epub 2017 Sep 26.
3
A focus on vaccination strategies.关注疫苗接种策略。
Viral Immunol. 2014 Nov;27(9):421. doi: 10.1089/vim.2014.1506.
4
Baculovirus as vaccine vectors.杆状病毒作为疫苗载体。
Curr Gene Ther. 2010 Jun;10(3):201-13. doi: 10.2174/156652310791321233.
5
New viral vectors for infectious diseases and cancer.新型病毒载体在传染病和癌症中的应用
Semin Immunol. 2020 Aug;50:101430. doi: 10.1016/j.smim.2020.101430. Epub 2020 Nov 29.
6
Nonhuman Adenoviral Vector-Based Platforms and Their Utility in Designing Next Generation of Vaccines for Infectious Diseases.基于非人类腺病毒载体的平台及其在设计传染病新一代疫苗中的应用。
Viruses. 2021 Jul 29;13(8):1493. doi: 10.3390/v13081493.
7
Utilizing poxviral vectored vaccines for antibody induction-progress and prospects.利用痘病毒载体疫苗诱导抗体:进展与展望。
Vaccine. 2013 Sep 6;31(39):4223-30. doi: 10.1016/j.vaccine.2013.05.091. Epub 2013 Jun 5.
8
Recombinant viruses as tools to induce protective cellular immunity against infectious diseases.重组病毒作为诱导针对传染病的保护性细胞免疫的工具。
Int Microbiol. 2004 Jun;7(2):83-94.
9
Predicting vaccine responsiveness.预测疫苗反应性。
Cell Host Microbe. 2015 Mar 11;17(3):301-307. doi: 10.1016/j.chom.2015.02.015.
10
Replicating and non-replicating viral vectors for vaccine development.用于疫苗开发的复制型和非复制型病毒载体
Curr Opin Biotechnol. 2007 Dec;18(6):546-56. doi: 10.1016/j.copbio.2007.10.010. Epub 2007 Dec 11.

引用本文的文献

1
Agricultural biotechnology in China: product development, commercialization, and perspectives.中国的农业生物技术:产品开发、商业化及前景
aBIOTECH. 2025 May 15;6(2):284-310. doi: 10.1007/s42994-025-00209-4. eCollection 2025 Jun.
2
Evaluation of Immunogenicity of an Orf Virus Vector-Based Vaccine Delivery Platform in Sheep.基于口疮病毒载体的疫苗递送平台在绵羊中的免疫原性评估。
Vaccines (Basel). 2025 Jun 11;13(6):631. doi: 10.3390/vaccines13060631.
3
Molecular mechanisms of immune evasion by host protein glycosylation of a bacterial immunogen used in nucleic acid vaccines.

本文引用的文献

1
Tuberculosis vaccines: present and future.结核病疫苗:现状与未来。
Expert Rev Respir Med. 2008 Dec;2(6):721-38. doi: 10.1586/17476348.2.6.721.
2
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.在泰国使用ALVAC和AIDSVAX疫苗预防HIV-1感染。
N Engl J Med. 2009 Dec 3;361(23):2209-20. doi: 10.1056/NEJMoa0908492. Epub 2009 Oct 20.
3
Viral vectors in malaria vaccine development.疟疾疫苗研发中的病毒载体
核酸疫苗中使用的细菌免疫原通过宿主蛋白糖基化实现免疫逃逸的分子机制。
bioRxiv. 2025 May 30:2025.05.29.656815. doi: 10.1101/2025.05.29.656815.
4
Evaluating Antigen- and Vector-Specific Immune Responses of a Recombinant Pichinde Virus-Based Vaccine Expressing the Lymphocytic Choriomeningitis Virus Nucleoprotein.评估一种表达淋巴细胞性脉络丛脑膜炎病毒核蛋白的基于重组皮钦德病毒的疫苗的抗原特异性和载体特异性免疫反应。
Vaccines (Basel). 2024 Dec 23;12(12):1450. doi: 10.3390/vaccines12121450.
5
Oncolytic adenovirus encoding decorin and CD40 ligand inhibits tumor growth and liver metastasis via immune activation in murine colorectal tumor model.携带 decorin 和 CD40 配体的溶瘤腺病毒通过免疫激活抑制小鼠结直肠肿瘤模型中的肿瘤生长和肝转移。
Mol Biomed. 2024 Sep 22;5(1):39. doi: 10.1186/s43556-024-00202-1.
6
Adenoviral Vector System: A Comprehensive Overview of Constructions, Therapeutic Applications and Host Responses.腺病毒载体系统:构建、治疗应用和宿主反应的全面概述。
J Microbiol. 2024 Jul;62(7):491-509. doi: 10.1007/s12275-024-00159-4. Epub 2024 Jul 22.
7
A Comprehensive Review of Our Understanding and Challenges of Viral Vaccines against Swine Pathogens.病毒性疫苗防治猪病的理解与挑战综述
Viruses. 2024 May 24;16(6):833. doi: 10.3390/v16060833.
8
Recent and advanced nano-technological strategies for COVID-19 vaccine development.用于新冠疫苗研发的最新及先进纳米技术策略
Methods Microbiol. 2022;50:151-188. doi: 10.1016/bs.mim.2022.03.001. Epub 2022 Apr 18.
9
Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy.变革癌症治疗:在免疫治疗新时代释放病毒疫苗、单克隆抗体和蛋白酶靶向嵌合体的力量。
ACS Omega. 2024 Feb 5;9(7):7277-7295. doi: 10.1021/acsomega.3c06501. eCollection 2024 Feb 20.
10
Nanoparticles and Antiviral Vaccines.纳米颗粒与抗病毒疫苗
Vaccines (Basel). 2023 Dec 27;12(1):30. doi: 10.3390/vaccines12010030.
Parasite Immunol. 2009 Sep;31(9):501-19. doi: 10.1111/j.1365-3024.2009.01141.x.
4
Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults.默克腺病毒5型(MRKAd5)和MRKAd6 1型人类免疫缺陷病毒三联基因疫苗单独及联合使用在健康成年人中的安全性和免疫原性。
Clin Vaccine Immunol. 2009 Sep;16(9):1285-92. doi: 10.1128/CVI.00144-09. Epub 2009 Jul 15.
5
HIV vaccine development: Lessons from the past, informing the future.HIV疫苗研发:回顾过去,展望未来。
IDrugs. 2009 Jul;12(7):435-9.
6
Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome.改良安卡拉痘苗病毒(MVA)的天然免疫传感由TLR2-TLR6、MDA-5和NALP3炎性小体介导。
PLoS Pathog. 2009 Jun;5(6):e1000480. doi: 10.1371/journal.ppat.1000480. Epub 2009 Jun 19.
7
Viral sequestration of antigen subverts cross presentation to CD8(+) T cells.病毒对抗原的隔离破坏了向CD8(+) T细胞的交叉呈递。
PLoS Pathog. 2009 May;5(5):e1000457. doi: 10.1371/journal.ppat.1000457. Epub 2009 May 29.
8
Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy.在疫苗载体效力背景下,肯尼亚儿童中针对黑猩猩腺病毒63型和人腺病毒5型的血清中和抗体流行情况。
Vaccine. 2009 Jun 2;27(27):3501-4. doi: 10.1016/j.vaccine.2009.03.080. Epub 2009 Apr 16.
9
Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogens.用编码1型人类免疫缺陷病毒C亚型免疫原的NYVAC加强免疫引发的人类和恒河猴T细胞反应的比较。
J Virol. 2009 Jun;83(11):5881-9. doi: 10.1128/JVI.02345-08. Epub 2009 Mar 25.
10
Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge.效应记忆T细胞反应与恒河猴免受黏膜猿猴免疫缺陷病毒攻击的保护作用相关。
Nat Med. 2009 Mar;15(3):293-9. doi: 10.1038/nm.1935. Epub 2009 Feb 15.